Literature DB >> 21982144

Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections.

S R Quist, G Fierlbeck, R A Seaton, J Loeffler, R L Chaves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21982144     DOI： 10.1016/j.ijantimicag.2011.08.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  11 in total

1.  Safety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trial.

Authors:  Alexander Konychev; Markus Heep; Rose K C Moritz; Alexander Kreuter; Alexander Shulutko; Gerhard Fierlbeck; Kamel Bouylout; Rashidkhan Pathan; Uwe Trostmann; Ricardo L Chaves
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

2.  Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.

Authors:  J Domínguez-Herrera; F Docobo-Pérez; R López-Rojas; C Pichardo; R Ruiz-Valderas; J A Lepe; J Pachón
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  Study on daptomycin use and implementation of an antimicrobial stewardship program.

Authors:  Camille Castel; Arnaud de La Blanchardière; Jocelyn Michon; Vincent Cattoir; Guillaume Saint-Lorant
Journal:  Int J Clin Pharm       Date:  2016-03-07

4.  Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE).

Authors:  Alberto Cogo; Armando Gonzalez-Ruiz; Rashidkhan Pathan; Kamal Hamed
Journal:  Infect Dis Ther       Date:  2015-07-14

Review 5.  Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis.

Authors:  Chao Liu; Zhi Mao; Mengmeng Yang; Hongjun Kang; Hui Liu; Liang Pan; Jie Hu; Jun Luo; Feihu Zhou
Journal:  Ther Clin Risk Manag       Date:  2016-09-22       Impact factor: 2.423

6.  Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections.

Authors:  Nobuaki Shime; Nobuyuki Saito; Miya Bokui; Naoki Sakane; Mitsuhiro Kamimura; Tsutomu Shinohara; Tadashi Kosaka; Hisashi Ishikura; Atsuko Kobayashi
Journal:  Infect Drug Resist       Date:  2018-08-06       Impact factor: 4.003

7.  The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections.

Authors:  Ewa Szczypinska; Alexander Velazquez; Diana Salazar; C Andrew Deryke; Beata Raczynski; Mark R Wallace
Journal:  Springerplus       Date:  2013-12-30

Review 8.  The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials.

Authors:  Shou Zhen Wang; Jun Tao Hu; Chi Zhang; Wei Zhou; Xian Feng Chen; Liang Yan Jiang; Zhan Hong Tang
Journal:  BMJ Open       Date:  2014-06-24       Impact factor: 2.692

Review 9.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003

10.  Comparative Efficacy and Safety of Vancomycin, Linezolid, Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven Complicated Skin and Soft Tissue Infections: An Updated Network Meta-Analysis.

Authors:  Jingjuan Feng; Feng Xiang; Jian Cheng; Yeli Gou; Jun Li
Journal:  Infect Dis Ther       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.